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1. Introduction 
The complement system is a multi-enzyme cascade 
found in blood plasma nd is a major defense system 
against invasion by foreign material [1 ]. Complement 
can be activated in plasma by two routes - the clas- 
sical pathway, consisting of components C1, C4 and 
C2 and the alternative pathway which involves erine 
proteases B and D. Both pathways result in activation 
of C3, the third component of complement which is 
the most abundant complement protein, present at 
1.3 mg/ml in plasma, Clinically, C3 depletion and the 
appearance of serologically defined C3 degradation 
fragments are used as measures of complement acti- 
vation. 
C3 is synthesised as a single polypeptide chain pre- 
cursor of ~200 000 M r which is subsequently cleaved 
into the two polypeptide chains (c~, 116 000 Mr;/3, 
70 000 Mr) of plasma C3 [2]. During complement 
activation, C3 is cleaved at a bond close to the amino- 
terminus of the a-chain forming two fragments, C3a 
(8000 Mr) and C3b (178 000Mr) (see fig.4). C3b has 
the transient ability to bind covalently through an 
ester or amide bond to nearby hydroxyl or amino 
groups [3]. 
The complement protein C4 is similar to C3 in its 
structure and properties and is cleaved into C4a and 
C4b fragments when complement is activated via the 
classical pathway. C3b and C4b, once formed, are 
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degraded by a specific protease (C3b/C4b inactivator) 
[ 1 ] and in each case C3b/C4b INA acts only in the 
presence of a specific glycoprotein cofactor-/3~H for 
C3b [4] and C4b-binding protein (C4bp) for C4b [5]. 
C4bp has also been reported to act as cofactor for 
C3b cleavage by C3b/C4b INA [6,7]. The ~'-chain of 
C4b is cleaved in two places by C3b/C4b INA [8,9]. 
However, there is controversy as to whether the 
a'-chain of C3b is cleaved at a single peptide bond 
[6,7,10-14] or in two places [15] by C3b/C4b INA. 
The product of C3b degradation by/31H and C3b/C4b 
INA is called C3bi. C3bi is itself broken down by un- 
identified serum proteases to final products C3c 
(140 000 Mr) and C3d (30 000 Mr). (see summary 
fig .4). 
We present evidence which shows that C3b, like 
C4b, is cleaved in two places by C3b/C4b INA. The 
double cleavage pattern occurs in serum and also 
when C3b is incubated with isolated/31H and C3 b/C4b 
INA. The second of the two cleavages can be prefer- 
entiaHy inhibited at low pH. The product formed by 
these two cleavages, C3bi, is a relatively stable species 
in serum, in that it is formed rapidly but its subsequent 
degradation is slow. 
2. Materials and methods 
2.1. Proteins and sera 
C3 and C3b were prepared and radio-iodinated 
using Iodogen (Pierce and Warriner, Chester) as in 
[16]./31H, C3b/C4b INA and C4bp were purified 
according to [17], [11] and [9], respectively. Isolated 
C3b/C4b INA was found to lose activity on prolonged 
storage at 4°C, although no change in polypeptide 
chain structure was observed. Haemolytically inactive 
C3 was produced by incubation of native, isolated C3 
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in 100 mM hydrazine (pH 9.0) for 1 h at 37°C. 
Human sera deficient in specific proteins were 
prepared by passage of pooled human serum through 
Sepharose 4B columns to which were bound mono- 
specific mouse or rabbit antibodies to the appropriate 
protein. These affinity columns, prepared as in [ 18], 
were run in 250 mM NaC1, 50 mM potassium phos- 
phate, 5 mM EDTA (pH 7.5) at 4°C to avoid comple- 
ment activation. 
2.2. C3b Degradation 
In serum: Samples (0.5-15.0/3g) of tzSI4abelled 
C3, 12SI-labelled hydrazine-inactivated C3 or 1251- 
labelled C3b (spec. act. 1.2 X 104-1.2 X 106 cpm//3g) 
were added to 2.5-10% (v/v) serum in a total volume 
of 100/31 of VBS 2+. Where indicated,/31H was added 
to a final concentration of 40/3g/ml, C4bp was added 
to a final concentration of 100/3g/ml and C3b/C4b 
INA was added to a final concentration of 4.5/3g/ml. 
These concentrations correspond approximately to
physiological levels of/31H, C4bp and C3b/C4b INA 
in 10% (v/v) human serum. 
In purified system: In a total volume of 100/31 
20 mM sodium phosphate, 5 mM EDTA (pH 6.5) 
samples (0.5-45/3g) of radio-iodinated C3, C3b or 
hydrazine-inactivated C3 (spec. act. 1.2 × 104- 
1.2 X 106 cpm//ag) were incubated with 10-40/3g 
/31H or C4bp and 0.15-0.2/3g C3b/C4b INA. In stud- 
ies of the effect of pH, all proteins were dialysed into 
150 mM NaC1 and incubated in a composite buffer of 
25 mM MES, 25 mM HEPES, 25 mM Tris and 25 mM 
glycine adjusted to the desired pH at 37°C, as in [19]. 
In both purified and serum systems, where men- 
tioned in the text, soya bean trypsin inhibitor (SBTI) 
was added to a final concentration of  100/3g/nil and 
di-isopropyl fluorophosphate (DFP) was added to a 
final concentration of 10 raM. Reaction mixtures 
were incubated at 37°C and samples (10/31) were 
withdrawn and mixed with 10/al 200 mM sodium 
phosphate, 8 M urea, 2% (w/v) SDS (pH 7.0) at vari- 
ous times to stop the reaction. 
SDS-PAGE of reduced and alkylated samples 
were performed as in [20]. Autoradiography of the 
stained, dried gels was used to observe the degrada- 
tion pattern of the radio-labelled proteins. Quantita- 
tion of degradation of radiolabelled proteins was 
determined by counting radioactivity in 1 mm strips 
cut from individual gel tracks (LKB Wallac 1270 
Rackgamma counter). In systems using isolated pro- 
teins, the rate of  degradation was also calculated from 
scanning the intensity at 540 nm of protein bands 
stained with Coomassie blue, using a Gelman DCD 16 
densitometer. 
3. Results 
3.1. Cleavage of C3b with purified ~IH and C3b/C4b 
INA 
When 12SI-labelled C3b is incubated with C3b/C4b 
INA and ~31H, the u'-chain of C3b is degraded (fig.la). 
In parallel with the decrease in intensity of the c~'-chain, 
which initially contains ~70% of the total radioactiv- 
ity of C3b, there is appearance of radioactivity associ- 
ated with polypeptide chains of 68 000, 46 000 and 
43 000 app. M r. Whereas the radioactivity associated 
with the 68 000 and 43 000 M r bands increases during 
the incubation period, the radioactivity of the 46 000 
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Fig.1. Pattern of degradation of ~2~14abeUed C3b. Radio- 
iodinated C3b was incubated with either isolated C3b/C4b 
INA + ;31H or with human serum as in section 2. Samples 
were removed at various times as indicated. Autoradiographs 
of SDS--PAGE of reduced and alkylated samples are shown 
in both frames: (a) ~2Sl-labelled C3b (45 ~g),/31tt (36 tag) and 
C3b/C4b INA (0.15 tag); (b) a2SI-labelled C3b (12 tag) in 10% 
(v/v) human serum. 
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M r band increases initially and then decreases (fig.2). 
The pattern of appearance of radioactive bands (fig.2) 
shows that the 46 000 M r species is the precursor of 
the 43 000 M r product. In this system, therefore, the 
C3b a'-chain (108 000 app. Mr) is first cleaved to 
form the 68 000 and 46 000 M r fragments. Further 
cleavage generates the 43 000 M r fragment from the 
46 000 M r chain (for summary see rigA). Neither 
SBTI nor DFP has any effect on the rate or pattern of 
cleavage of C3b. 
Examination of cleaved C3b (C3bi) by SDS-PAGE 
without prior reduction shows that the 13-chain, 
68 000 and 43 000 (or 46 000)M r fragments remain 
disulphide-linked to each other. 
Fig.2. Time-course of production of  C3bi. The gel tracks used 
to provide the autoradiograph s own in fig.la were cut into 
1 mm strips. The radioactivity associated with the ~'-chain 
(=), 68 000 M r fragment (z~), 46 000 M r fragment (o) and 
43 000 M r fragment (o) of  the a'-chain have been expressed 
as a percentage of  the total radioactivity in each track. Radio- 
activity associated with the 68 000 M r band has been corrected 
for radioactivity due to the 13-chain (25% of total at zero time). 
3.2. C3b degradation in serum 
When lzSI-labeUed C3b is incubated with human 
serum, the ~'-chain is degraded rapidly (fig. lb) and 
the degradation pattern is identical to that seen in the 
purified system (fig.la). The band at 68 000 M r in 
fig.lb is distorted, as is the t3-chain of C3b (70 000 
Mr) because of the overload of albumin from serum 
which migrates in the same position. As in the purified 
system, SBTI and DFP have no effect on these stages 
of C3b breakdown in human serum (table 1). 
Table 1 
Rate of  C3bi production in serum 
Serum Additions Half-life of  C3b a'-chain 
Normal serum - 0 .6 -  2.0 min 
Normal serum DFP 0 .6 -  2.0 min 
Normal serum SBTI 0 .6 -  2.0 min 
Serum depleted of 13~H - 22.5 h 
Serum depleted of~aH /3~H 4 .0 -  9.0 min 
Serum depleted of C4bp - 4 .0 -15 .0  rain 
Serum depleted of  C4bp C4bp 4 .5 -10 .0  min 
Serum depleted of  ~31H and C4bp - >24 h 
Serum depleted of ~1H and C4bp C4bp >24 h 
Serum depleted of~3~ H and C4bp 13~ H 4.2 min 
Serum depleted of~3~H and C4bp 131H + C4bp 6.5 min 
Serum depleted of  C3b/C4b INA 
Serum depleted of C3b/C4b INA C3b/C4b INA 
15 h 
4.6 rain 
The rate of  cleavage of  the cg-chain of 125I-labelled C3b (final conc. 120 ~g/ml) in 10% 
(v/v) human serum, incubated as in section 2, was determined from graphs drawn as 
shown in fig.2. The half-life is expressed as the time required for disappearance of 50% 
of the a'-chain. When only one value is shown results are the average of two determina- 
tions. Where a range of  values is indicated, at least 4 independent experiments have been 
performed 
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Fig.3. Effect ofpH on cleavage ofC3b, a2SI-Labelled C3b 
(0.5 #g, spec. act. 1.26 X 10 ~ cpm/#g) was incubated for 
various times with ~3~ H (10 #g) and C3b/c4b INA (0.2 ug) in 
a composite buffer as in section 2: (a) pH 4.78; (b) pH 5.21; 
(c) pH 6.07. Autoradiographs of SDS-PAGE of reduced and 
alkylated samples are shown. The gel track on the extreme 
right shows C3b alone incubated atpH 4.68. 
Even when ~2SI-labelled C3b is incubated in 10% 
(v/v) human serum for up to 6 h at 37°C very little 
degradation of C3b beyond the C3bi stage is observed 
and from studies of prolonged incubation we have 
estimated that after 2 days at 37°C only 50% of C3bi 
is degraded further to C3c and C3d. 
The degradation of 12SI-labelled human C3b to 
C3bi in sera from other species follows the same pat- 
tern as seen in rigA. Both the 46 000 and 43 000M r 
fragments are observed when ~zSI-labelled human C3b 
is incubated at 37°C in 5% (v/v) mouse, guinea pig 
and foetal calf serum. The double cleavage pattern 
appears in these other sera even although the rates of 
C3bi production differ. The half-life of human C3b in 
5% (v/v) guinea pig, rabbit or foetal calf serum is <15 
rain, whereas in 5% (v/v) mouse serum it has a half-life 
of 2 -3  h. In 5% (v/v) chicken serum, 12SI-labelled C3b 
was stable for at least 24 h. 
When haemolytically active ~2SI-labelled C3 is 
incubated with human serum the radio-labelled pro- 
tein appears as intact C3 for at least 6 h. In contrast, 
~2SI-labelled C3, which has been treated with hydrazine 
to break the internal thiol ester bond in native C3, is 
degraded in human serum at the same rate as ~2Sl- 
labelled C3b. The a-chain of haemolytically inactive 
C3 is cleaved to 76 000 and 43 000M r fragments with 
the transient appearance of a 46 000 M r fragment. 
3.3. Effect of  pH on C3b cleavage 
The pH optimum for C3b/C4b INA activity is pH 
September 1981 
6.0-6.5 [ 11,21 ] as measured by haemolytic assay. 
We have found a similar pH optimum for degradation 
of the c~'-chain. At more acidic pH-values, the rate of 
the second cleavage appears to be selectively decreased. 
At pH 4.78 the 46 000 M r species increases over the 
incubation period (fig.3a) with negligible production 
of the 43 000M r polypeptide. At pH 5.21, the 
46 000 M r species appears transiently and the amount 
of 43 000 M r fragment increases throughout the incu- 
bation period (fig.3b). At the pH optimum for the 
overall reaction the 46 000 M r species is very short- 
lived (fig.3c). 
3.4. Role of serum cofactors 
To test the physiological role of 3~H and C4bp in 
serum as cofactors in C3b breakdown to C3bi, the 
rate of degradation of the E-chain of C3b was mea- 
sured in human serum and human serum which had 
been depleted of/3~H and C3bp. In normal serum, 
C3b is degraded very rapidly to C3bi, with a half- 
life of ~1 nfin (table 1). The half-life of C3b in sermn 
from which/3~H has been removed is increased ra- 
matically to 22.5 h. Re-addition of 31H at a physiolog- 
ical level to this serum decreases the half-life to 
/3 
N 
,a 
N 
t 
,,a 
N 
I 
~, Conver tase, 
• ]i • C 
~IH, C3b ina 
,a 
C3a 
C3b 
i • 46 
~, ,~lH,C3b ina 
. ~ ~ c  C3 bi 
(~) ~.,L Trypt i~enzymes 
m 
C3d 
Fig.4. Sunnnary of degradation ofC3. Activation of C3 by 
C3 convertase cleaves the C3a fragment from the N-terminus 
of the ~-chain and reveals the reactive acyl-group which is 
shown by the spike in the c(-chain of C3b. The spike also 
indicates the site of autolytic leavage ofC3 [27 ]. Two cleav- 
ages of C3b by 13tH and C3b/C4b INA are shown. The small 
fragment released from the 46 000 M r polypeptide may come 
from either end of the 46 000 M r fragment. Further degra- 
dation of C3bi by serum enzymes forms C3c, which consists 
of an intact g-chain and E-chain fragments of ~25 000 and 
38 000 M r and C3d. The position and number of disulphide 
bridges, indicated by thin lines, is arbitrary. 
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5 min. Removal of C4bp from serum increases the 
half-life of C3b slightly compared with normal serum 
but readdition of C4bp to this serum has no effect on 
the stability of C3b. C3b is extremely stable in serum 
which has been depleted of both 31H and C4bp (half- 
life > 24 h) but is rendered much less stable (half-life 
5 min) when 31H alone is restored. Re-addition of 
C4bp has no effect on the stability of C3b in serum 
depleted of both 31H and C4bp, irrespective ofwhether 
/31H has been restored. The residual cleavage of C3b 
in/31H-depleted serum follows the same degradation 
pattern as shown in fig.lb and is likely to be due to 
<1% remaining 31H. 
It can be concluded from these results that C4bp 
does not have a significant role in C3b cleavage in 
human serum. In experiments with isolated proteins, 
however, C4bp does act as a cofactor in C3b cleavage, 
as in [6,7]. We have found that C4bp is ~5% as effec- 
tive as/31H on a weight basis. The double cleavage 
pattern of the a'-chain of C3b is again observed. 
4. Discussion 
These results how clearly in a purified system 
with C3b/C4b INA and 31H that the a'-chain of C3b 
is cleaved at more than one peptide bond. The observed 
degradation pattern is the same whether pure C3b/ 
C4b INA and/31H are used or whether human or some 
other animal sera are used as the source of these pro- 
teins. The cleavage products are very likely to be the 
result of hydrolysis of only two peptide bonds but 
additional proteolytic removal of small oligopeptides 
from the main 68 000, 46 000 and 43 000 M r frag- 
ments cannot be discounted. The double cleavage 
pattern occurs in a purified system and is not inhibited 
by DFP and SBTI. It is therefore unlikely that non- 
specific proteolysis by contaminating proteases (e.g., 
plasmin, kaUikrein or thrombin) contributes to pro- 
duction of either the 46 000 or 43 000 M r fragments. 
The formation of C3bi described here is in agree- 
ment with the findings in [15]. The failure to observe 
the double cleavage of the a'-chain of C3b in [6,7, 
10-14] may be explained by the transient appearance 
of the 46 000 M r fragment, especially around neutral 
pH. We have found that the 46 000M r band is more 
readily observed by autoradiography than by 
Coomassie blue staining of SDS-polyacrylamide g ls. 
When C3b is generated from C3 an internal thiol 
ester in native C3 is hydrolysed. The thiolester bond 
can also be broken by treatment of C3 with nucleo- 
philes and chaotropes without proteolysis, and 
haemolytically inactive C3 is produced. This inactive 
C3 has the same polypeptide chain structure as native 
C3 [20,22,23]. Inactive C3 can be further distinguished 
from native C3 in that it is susceptible to cleavage by 
C3b/C4b INA and 31H ([I 1,24] and section 3). When 
inactive C3 is cleaved by C3b/C4b INA in the presence 
of3lH, a 74 000M r fragment and a 46 000M r inter- 
mediate is produced which is further cleaved to a 
43 000 M r polypeptide. The 43 000 M r fragment cor- 
responds to the C-terminal portion of the a-chain of 
C3 [ 11,24,25 ]. The other, (74 000 Mr) fragment is 
eventually broken down in serum to form C3d [12]. 
The cleavage of inactive C3 by C3b/C4b INA and 
131H is completely distinct from the denaturation- 
induced autolytic leavage of native C3 [ 17], although 
the denaturation-induced leavage reaction does gener- 
ate fragments of similar size (74 000 and 46 000 Mr) 
from the a-chain of C3. We have observed that on 
autolytic leavage of 12SI-labelled active C3 that 66-  
70% of the radioactivity of the a-chain is associated 
with the small (46 000 Mr) fragment. In contrast, 
with C3b/C4b INA and 31H-dependent cleavage of 
radio-iodinated inactive C3, only 25% of the radio- 
activity of the c~-chain s associated with the 46 000 
and 43 000 M r fragments. These data support he 
conclusion that the autolytic leavage point and the 
C3b/C4b INA cleavage sites, although producing sim- 
ilarly sized fragments, are at opposite nds of the 
a-chain of C3. The 46 000 M r fragment produced by 
autolytic leavage corresponds therefore to the N-ter- 
minal portion of the c~-chain. 
The C3d fragment derived by trypsin digestion of 
radio-iodinated C3 in agreement with [26] contains 
only 7-12% of the radioactivity of the C3 c~-chain. 
By consideration of the content of radioactivity of 
the N-terminal and C-terminal fragments produced by 
the two types of cleavage discussed above, it is evident 
that C3d is derived from the central portion of the 
a-chain of C3. A summary of the degradation of C3 is 
shown on rigA. 
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